Answers are grounded in this paper and cite their sources.
Supplementary Figure S3 shows cell viability assays of KTOR27 cells treated with afatinib and VT103.
No takes yet. Share an insight, caveat, or question.
Ogimoto et al. (2024) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: